Advanced search
Publication Cover
Pharmaceutical Development and Technology Volume 3, 1998 - Issue 4
Submit an article Journal homepage
345
Views
19
CrossRef citations to date
0
Altmetric
Research Article

The Impact of Formulation and Process Changes on In Vitro Dissolution and the Bioequivalence of Piroxicam Capsules

Deborah A. Piscitelli Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland
,
Sian Bigora Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland
,
Cecil Propst Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland
,
Sanjay Goskonda Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland
,
Paul Schwartz Food and Drug Administration, 1451 Rockville Pike, Rockville, Maryland
,
Lawrence J. Lesko Food and Drug Administration, 1451 Rockville Pike, Rockville, Maryland
,
Larry Augsburger Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland
&
David Young Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland
 show all
Pages 443-452 | Received 28 Jan 1997, Accepted 09 Jan 1998, Published online: 27 Sep 2008

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ahmed Abd El-Bary, Ibrahim Al Sharabi & Balqees Saeed Haza'a. (2019) Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an in vitro/in silico study. Drug Development and Industrial Pharmacy 45:11, pages 1751-1769.
Read now

Articles from other publishers (18)

Asmita Adhikari, Paul R. Seo & James E. Polli. (2023) Dissolution-Hollow Fiber Membrane (D-HFM) System to Anticipate Biopharmaceutics Risk of Tablets and Capsules. Journal of Pharmaceutical Sciences 112:3, pages 751-759.
Crossref
Chang‑Keun Cho, Pureum Kang, Hye-Jung Park, Eunvin Ko, Chou Yen Mu, Yun Jeong Lee, Chang-Ik Choi, Hyung Sik Kim, Choon-Gon Jang, Jung‑Woo Bae & Seok-Yong Lee. (2022) Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism. Archives of Pharmacal Research 45:5, pages 352-366.
Crossref
Xiaoting Li, Yuanhang Yang, Yu Zhang, Chunnuan Wu, Qikun Jiang, Weiping Wang, Huixin Li, Jing Li, Cong Luo, Wenying Wu, Yingli Wang & Tianhong Zhang. (2019) Justification of Biowaiver and Dissolution Rate Specifications for Piroxicam Immediate Release Products Based on Physiologically Based Pharmacokinetic Modeling: An In-Depth Analysis. Molecular Pharmaceutics 16:9, pages 3780-3790.
Crossref
Xiaoting Li, Yan Gao, Jia Liu, Gongtian Zhang & Tianhong Zhang. (2018) A rapid analysis of piroxicam in beagle plasma applying evaporation-free liquid-liquid extraction by supercritical fluid chromatography-tandem mass spectrometry. Journal of Chromatography B 1100-1101, pages 93-99.
Crossref
Huiquan Wu, Lin Xie, Stephen Hoag, Larry Augsburger & Mansoor Khan. 2017. Pharmaceutical Dosage Forms. Pharmaceutical Dosage Forms 393 414 .
Bhushan Munjal, Vishal Koradia, Sai HS. Boddu & Arvind K. Bansal. 2015. Excipient Applications in Formulation Design and Drug Delivery. Excipient Applications in Formulation Design and Drug Delivery 521 538 .
Igor E. Shohin, Julia I. Kulinich, Galina V. Ramenskaya, Bertil Abrahamsson, Sabine Kopp, Peter Langguth, James E. Polli, Vinod P. Shah, D.W. Groot, Dirk M. Barends & Jennifer B. Dressman. (2014) Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Piroxicam. Journal of Pharmaceutical Sciences 103:2, pages 367-377.
Crossref
Igor E. Shohin, Julia I. Kulinich, Galina V. Ramenskaya, Bertil Abrahamsson, Sabine Kopp, Peter Langguth, James E. Polli, Vinod P. Shah, D.W. Groot, Dirk M. Barends & Jennifer B. Dressman. (2012) Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Ketoprofen. Journal of Pharmaceutical Sciences 101:10, pages 3593-3603.
Crossref
Jim E. RiviereMarilyn Martinez. 2011. Comparative Pharmacokinetics. Comparative Pharmacokinetics 315 346 .
Hong Wen & Kinam Park. 2010. Oral Controlled Release Formulation Design and Drug Delivery. Oral Controlled Release Formulation Design and Drug Delivery 1 19 .
Paul A. Dickinson, Wang Wang Lee, Paul W. Stott, Andy I. Townsend, John P. Smart, Parviz Ghahramani, Tracey Hammett, Linda Billett, Sheena Behn, Ryan C. Gibb & Bertil Abrahamsson. (2008) Clinical Relevance of Dissolution Testing in Quality by Design. The AAPS Journal 10:2, pages 380-390.
Crossref
Pallavi Nithyanandan, Walter W. Hauck, Jimmy Munoz, Gang Deng, William Brown, Ronald G. Manning & Samir Wahab. (2008) Dissolution Variability: Comparison of Commercial Dosage Forms with US Pharmacopeia Lot P Prednisone Reference Standard Tablets—A Technical Note. AAPS PharmSciTech 9:1, pages 238-242.
Crossref
C. Rasetti-Escargueil & V. Grangé. (2005) Pharmacokinetic profiles of two tablet formulations of piroxicam. International Journal of Pharmaceutics 295:1-2, pages 129-134.
Crossref
Saeed A Qureshi & Javad Shabnam. (2003) Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products. European Journal of Pharmaceutical Sciences 19:4, pages 291-297.
Crossref
Timothy Crowder. 2003. A Guide to Pharmaceutical Particulate Science. A Guide to Pharmaceutical Particulate Science.
Marilyn N. Martinez & Gordon L. Amidon. (2013) A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals. The Journal of Clinical Pharmacology 42:6, pages 620-643.
Crossref
Kimberley Jackson, David Young & Sonia Pant. (2000) Drug–excipient interactions and their affect on absorption. Pharmaceutical Science & Technology Today 3:10, pages 336-345.
Crossref
Mark J. Ginski, Rajneesh Taneja & James E. Polli. (1999) Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system. AAPS PharmSci 1:2, pages 27-38.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.